Ginkgo and Compazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ginkgo (ginkgo) and Compazine (prochlorperazine maleate). Common drug interactions include dehydration among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Ginkgo and Compazine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Ginkgo?

Ginkgo has active ingredients of ginkgo. It is often used in memory loss. eHealthMe is studying from 4,473 Ginkgo users. Check the latest studies of Ginkgo.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

On Aug, 13, 2026

12 people who take Ginkgo and Compazine together, and have interactions are studied.

What are the common drug interactions of Ginkgo and Compazine, by gender? *:

female:

Dehydration (dryness resulting from the removal of water)
Chronic kidney disease
Dysphagia (a condition in which swallowing is difficult or painful)
Renal impairment (severely reduced kidney function)
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
Diarrhoea
Fatigue (feeling of tiredness)
Full blood count increased
Nephrogenic anaemia (anaemia due to kidney disease)
Renal injury (kidney injury)

male:

Dizziness
Sleep disorder
Balance disorder
Dysarthria (speech disorder)
Gait disturbance
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Muscular weakness (muscle weakness)
Rash erythematous (redness of the skin)
Rash pruritic (redness with itching)

What are the common drug interactions of Ginkgo and Compazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
Cerebral atrophy (decrement in size of brain)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dizziness
Intervertebral disc degeneration (spinal disc degeneration)
Intervertebral disc protrusion (spinal disc protrusion)
Neuropathy peripheral (surface nerve damage)
Sleep disorder
Visual impairment
Ataxia (loss of full control of bodily movements)

50-59:

n/a

60+:

Asthenia (weakness)
Blood pressure decreased
Haemorrhage (bleeding)
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Myalgia (muscle pain)
Sepsis (a severe blood infection that can lead to organ failure and death)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 7 people, 58.33%
High Blood Pressure: 5 people, 41.67%
Pain: 4 people, 33.33%
Asthma: 4 people, 33.33%
Insomnia (sleeplessness): 3 people, 25.00%
Stress And Anxiety: 3 people, 25.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 25.00%
Headache (pain in head): 3 people, 25.00%
Muscle Spasms (muscle contraction): 3 people, 25.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ginkgo and Compazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously